StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

Assembly Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2010 it was $419.38K.

Annual total debt

PeriodPeriod endValueChange
FY2010Dec 31, 2010$419.38K–

More Assembly Biosciences figures

See a number that looks wrong?